Thioridazine
(NZFNXWQNBYZDAQ-UHFFFAOYSA-N)
Structure
- SMILES
- CSc1ccc2c(c1)N(CCC1CCCCN1C)c1c(S2)cccc1.Cl
- Molecular Formula:
- C21H27ClN2S2
- Molecular Weight:
- 407.035
- Log P:
- 6.6905
- Hydrogen Bond Acceptor:
- 3
- Hydrogen Bond Donor:
- 1
- TPSA:
- 57.08
- CAS Number(s):
- 130-61-0
Synonym(s)
1.
Thioridazine
2.
Aldazine
3.
Apo-Thioridazine
4.
Meleril
5.
Mellaril
6.
Melleretten
7.
Melleril
8.
Melleryl
9.
Melzine
10.
Rideril
11.
Sonapax
12.
Thioridazine HCL
13.
Thioridazine Hydrochloride
14.
Thioridazine-Neurazpharm
15.
Thiozine
16.
Apo Thioridazine
17.
ApoThioridazine
18.
Thioridazine Neurazpharm
19.
ThioridazineNeurazpharm
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Sudden death | FAERS: 4 | US FAERS | |
| 2 | Epilepsy | FAERS: 3 | US FAERS | |
| 3 | Overdose | FAERS: 3 | US FAERS | |
| 4 | Blindness | FAERS: 2 | US FAERS | |
| 5 | Completed Suicide | FAERS: 2 | US FAERS | |
| 6 | Drug ineffective | FAERS: 2 | US FAERS | |
| 7 | Drug level above therapeutic | FAERS: 2 | US FAERS | |
| 8 | Headache | FAERS: 2 | US FAERS | |
| 9 | Intentional misuse | FAERS: 2 | US FAERS | |
| 10 | Medication Error | FAERS: 2 | US FAERS | |
| 11 | Muscle Rigidity | FAERS: 2 | US FAERS | |
| 12 | Musculoskeletal stiffness | FAERS: 2 | US FAERS | |
| 13 | Opisthotonus | FAERS: 2 | US FAERS | |
| 14 | Tremor | FAERS: 2 | US FAERS | |
| 15 | Abdominal discomfort | FAERS: 1 | US FAERS | |
| 16 | Agitation | FAERS: 1 | US FAERS | |
| 17 | Alanine Aminotransferase Increased | FAERS: 1 | US FAERS | |
| 18 | Ammonia increased | FAERS: 1 | US FAERS | |
| 19 | Bronchopneumonia | FAERS: 1 | US FAERS | |
| 20 | Cardiac Arrest | FAERS: 1 | US FAERS | |
| 21 | Depressed mood | FAERS: 1 | US FAERS | |
| 22 | Drug Dependence | FAERS: 1 | US FAERS | |
| 23 | Drug dispensing error | FAERS: 1 | US FAERS | |
| 24 | Drug exposure during pregnancy | FAERS: 1 | US FAERS | |
| 25 | Drug screen positive | FAERS: 1 | US FAERS | |
| 26 | Drug toxicity | FAERS: 1 | US FAERS | |
| 27 | Electrocardiogram T wave biphasic | FAERS: 1 | US FAERS | |
| 28 | Electrocardiogram abnormal | FAERS: 1 | US FAERS | |
| 29 | Electroencephalogram abnormal | FAERS: 1 | US FAERS | |
| 30 | Feeling abnormal | FAERS: 1 | US FAERS | |
| 31 | Nausea | FAERS: 1 | US FAERS | |
| 32 | Obsessive-Compulsive Disorder | FAERS: 1 | US FAERS | |
| 33 | Palpitations | FAERS: 1 | US FAERS | |
| 34 | Paranoia | FAERS: 1 | US FAERS | |
| 35 | Pharmaceutical product complaint | FAERS: 1 | US FAERS | |
| 36 | Poor quality drug administered | FAERS: 1 | US FAERS | |
| 37 | Product availability issue | FAERS: 1 | US FAERS | |
| 38 | Product taste abnormal | FAERS: 1 | US FAERS | |
| 39 | Retinal depigmentation | FAERS: 1 | US FAERS | |
| 40 | Retinal toxicity | FAERS: 1 | US FAERS | |
| 41 | Syncope | FAERS: 1 | US FAERS | |
| 42 | Tardive Dyskinesia | FAERS: 1 | US FAERS | |
| 43 | Unevaluable event | FAERS: 1 | US FAERS | |
| 44 | Urinary Incontinence | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.